---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-017731"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2024-05-03T23:59:59+00:00"
generated_at: "2026-06-02T23:13:12.056317+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Serina Therapeutics replaces Withum with Frazier & Deeter as auditor after merger

## Summary
- Audit committee approved Frazier & Deeter as independent auditor for FY2024, replacing Withum.
- Withum's reports for FY2022 and FY2023 had no adverse opinion except going concern doubt.
- No disagreements with Withum on accounting principles or audit scope during those periods.
- Withum provided a letter (Exhibit 16.1) agreeing with the disclosures in this filing.

## SEC filing metadata
- accession: 0001493152-24-017731
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2024-05-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315224017731/0001493152-24-017731-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315224017731/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-017731
- JSON: https://secwatch.observer/filing/0001493152-24-017731.json
- Plain text: https://secwatch.observer/filing/0001493152-24-017731.txt

## Key facts
- Auditor Changes
  Serina Therapeutics, Inc. dismissed WithumSmith+Brown, PC as its auditor.
  - Action: dismissal
  - Auditor: WithumSmith+Brown, PC
  - Successor: Frazier & Deeter, LLC
  source text: ithumSmith+Brown, PC (“ Withum ”), the Company’s independent registered public accounting firm prior to the Merger, was informed that it would be dismissed and replaced by Frazier & Deeter. The reports of Withum on the Company’s financial statements for each of the two fiscal years ended December 31, 2023 and 2022 did not
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315224017731/0001493152-24-017731-index.htm
- Auditor Changes
  Serina Therapeutics, Inc. engaged Frazier & Deeter, LLC as its auditor.
  - Action: engagement
  - Auditor: Frazier & Deeter, LLC
  source text: pril 29, 2024, the Audit Committee of the Board of Directors of the Company approved, on behalf of the Company, the engagement of Frazier & Deeter, LLC (“ Frazier & Deeter ”) as the Company’s independent registered public accounting
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315224017731/0001493152-24-017731-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.